Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients.
about
Impact of IL28B, ITPA and PNPLA3 genetic variants on therapeutic outcome and progression of hepatitis C virus infectionProgress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicityGenome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis CITPA Polymorphisms Are Associated with Hematological Side Effects during Antiviral Therapy for Chronic HCV InfectionPharmacogenetics of efficacy and safety of HCV treatment in HCV-HIV coinfected patients: significant associations with IL28B and SOCS3 gene variantsRole of IL28B and inosine triphosphatase polymorphisms in the treatment of chronic hepatitis C virus genotype 6 infection.Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3.Association between IPTA gene polymorphisms and hematological abnormalities in hepatitis C virus-infected patients receiving combination therapy.IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infectionClinical utility of pharmacogenomics in the management of hepatitis C.An index to predict ribavirin-induced anemia in asian patients with chronic genotype 1 hepatitis CGenome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease.Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis CRoles of ITPA and IL28B genotypes in chronic hepatitis C patients treated with peginterferon plus ribavirin.Pharmacogenomics of hepatitis C infections: personalizing therapy.The ITPA and C20orf194 Polymorphisms and Hematological Changes During Treatment With Pegylated-Interferon Plus Ribavirin in Patients With Chronic Hepatitis C.Temperature rise after peginterferon alfa-2a injection in patients with chronic hepatitis C is associated with virological response and is modulated by IL28B genotype.Unexpected hematologic effects of biotherapeutics in nonclinical species and in humans.Host genetic variants influencing the clinical course of hepatitis C virus infection.Increase in platelet count based on inosine triphosphatase genotype during interferon beta plus ribavirin combination therapy.Association between genetic polymorphisms of the IL28B gene and leukomonocyte in Chinese hepatitis B virus-infected individuals.
P2860
Q26801381-B6039D92-2203-4ACD-8651-98487A42FCD4Q28083100-97FC967E-0204-4248-B23F-2667DF7242FFQ28254011-305F46DE-593C-4EC6-A84A-F3E94A101855Q28606732-701882E3-AB28-4AFE-AB7C-FE3C28FEED9DQ33404251-EC6D74CB-D8FB-4E54-80FC-BEB4EF0078DFQ33408167-1BF291C6-B1EA-4796-AD44-3E2D618A3FBBQ33413296-2D72EFE5-555F-4943-BB6F-188F036A82EBQ33418008-EC6315BA-E4A3-4042-B4CC-D091DD09DD0DQ33586624-651EB4D3-BBE0-4A8E-885C-BE8CC2FFE476Q34464613-58AA0484-9449-4747-A2A7-A300DD8A137CQ35226233-DA750502-3ADB-4C86-8BE7-99F470EAAD17Q35565624-58C2EE1C-C0FE-4211-A51A-2A3045D297DFQ35567714-3E9D4621-5196-466C-B5C4-8E37A1FC2067Q36246785-6F62E6B9-5837-4183-A319-654CA65FB7B2Q36632938-93E1326F-9A55-4CE3-853D-7AE412A48A91Q36853851-DD8BF436-A94A-471C-9A9A-2AB7DE0ACC1BQ37377964-7C4D1C8B-7BC5-4A3D-B842-5014432363B6Q38087506-4E9EAE38-D46E-4D3E-8CAA-AA1A3D7EA92BQ38554500-9E9692C4-957F-46DE-8A92-F1CF668F49EAQ42980055-81BB463D-B181-4183-AB2D-992048DB7E10Q47110542-D83DE243-AD08-40FB-A5A6-5D5B782BA5B2
P2860
Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Genome-wide association study ...... chronic hepatitis C patients.
@ast
Genome-wide association study ...... chronic hepatitis C patients.
@en
type
label
Genome-wide association study ...... chronic hepatitis C patients.
@ast
Genome-wide association study ...... chronic hepatitis C patients.
@en
prefLabel
Genome-wide association study ...... chronic hepatitis C patients.
@ast
Genome-wide association study ...... chronic hepatitis C patients.
@en
P2093
P2860
P50
P1476
Genome-wide association study ...... chronic hepatitis C patients.
@en
P2093
Abanish Singh
Alexander J Thompson
Andrew J Muir
Clifford A Brass
David B Goldstein
Dongliang Ge
Eric J Lawitz
Greg W Galler
Hans L Tillmann
Ira M Jacobson
P2860
P304
P356
10.1016/J.JHEP.2011.04.021
P577
2011-05-20T00:00:00Z